Notícias Adial Pharmaceuticals Inc - ADIL | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Adial Pharmaceuticals Inc (ADIL)
Adial Pharmaceuticals Inc (ADIL) Notícias

Adial Pharmaceuticals Inc (ADIL)

0,738

0,019

(2,64%)

Fechado 24 Março 5:00PM

Atrasado por 15 minutos

0,7372

-0,0008

(-0,11%)

Após o horário de negociação: 8:55PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form 8-K - Current report

Form 8-K - Current report

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

Form 8-K - Current report

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Form 8-K - Current report

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Adial Pharmaceuticals

Brookfield Infrastructur...

Stellar Holdings

Axsome Therapeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições